Obesity increases risk of severe infections, study finds
A new study suggests that people with obesity have higher rates of mortality and hospitalization from a variety of infections from viruses, fungi, parasites and bacteria
The next wave of GLP-1 drugs are coming—and they’re stronger than Wegovy and Zepbound
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much
Inside the Weight-Loss Drug Revolution: Promises, Pitfalls and a Pharma Arms Race
Behind the hype of GLP-1 medications lies complex science, serious side effects and a pharmaceutical arms race.
Weight and Health Benefits Vanish Fast after Quitting Weight-Loss Drugs, Study Finds
A new study finds that people who quit weight-loss medications, including GLP-1 drugs, regain weight four times faster than people who stop dieting or exercising
Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means
The first GLP-1 pills for weight loss are hitting U.S. pharmacies. But how will they be prescribed?
7 Important Health Stories to Watch in 2026
From immune cell therapies to measles outbreaks to federal attacks on public health, these are some of the health topics we’ll be watching next year
U.S. Approves Wegovy Weight-Loss Pill, a Move That Could Transform Health Care
A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care
Heart and Kidney Diseases and Type 2 Diabetes May Be One Ailment
These three disorders could really be “CKM syndrome,” which can be treated with drugs like Ozempic
‘Saving Room’ for a Big Thanksgiving Dinner Can Be Bad for Gut Health
Skipping meals before a big holiday feast probably isn’t the best idea for gut health, experts say. Here’s how to prevent overeating on an empty stomach—and tips for if you do
GLP-1 Pill Fails to Slow Alzheimer’s Progression in Clinical Trial
Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression
Why Drugs Like Ozempic Can Make People Drink Less Alcohol
A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight into potential new addiction therapies
People Who Don’t Lose Weight on Wegovy May Have Genetic Differences
Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others